These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21292879)

  • 1. Evaluation of the naturally acquired antibody immune response to the Pv200L N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon Region of Brazil.
    Storti-Melo LM; Souza-Neiras WC; Cassiano GC; Taveira LC; Cordeiro AJ; Couto VS; Póvoa MM; Cunha MG; Echeverry DM; Rossit AR; Arévalo-Herrera M; Herrera S; Machado RL
    Am J Trop Med Hyg; 2011 Feb; 84(2 Suppl):58-63. PubMed ID: 21292879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and humoral immune responses against the Plasmodium vivax MSP-1₁₉ malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil.
    Riccio EK; Totino PR; Pratt-Riccio LR; Ennes-Vidal V; Soares IS; Rodrigues MM; de Souza JM; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Malar J; 2013 Sep; 12():326. PubMed ID: 24041406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
    Soares IS; Oliveira SG; Souza JM; Rodrigues MM
    Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally acquired antibodies to merozoite surface protein (MSP)-1(19) and cumulative exposure to Plasmodium falciparum and Plasmodium vivax in remote populations of the Amazon Basin of Brazil.
    Ladeia-Andrade S; Ferreira MU; Scopel KK; Braga EM; Bastos Mda S; Wunderlich G; Coura JR
    Mem Inst Oswaldo Cruz; 2007 Dec; 102(8):943-51. PubMed ID: 18209933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran.
    Mehrizi AA; Zakeri S; Salmanian AH; Sanati MH; Djadid ND
    Acta Trop; 2009 Oct; 112(1):1-7. PubMed ID: 19481997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria transmission and individual variability of the naturally acquired IgG antibody against the Plasmodium vivax blood-stage antigen in an endemic area in Brazil.
    Costa EMF; Amador ECC; Silva ES; Alvarenga CO; Pereira PE; Póvoa MM; Cunha MG
    Acta Trop; 2020 Sep; 209():105537. PubMed ID: 32454033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit.
    Valderrama-Aguirre A; Quintero G; Gómez A; Castellanos A; Pérez Y; Méndez F; Arévalo-Herrera M; Herrera S
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):16-24. PubMed ID: 16291762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay.
    Fernandez-Becerra C; Sanz S; Brucet M; Stanisic DI; Alves FP; Camargo EP; Alonso PL; Mueller I; del Portillo HA
    Malar J; 2010 Jan; 9():29. PubMed ID: 20092651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
    Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
    Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
    Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
    Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1.
    Soares IS; da Cunha MG; Silva MN; Souza JM; Del Portillo HA; Rodrigues MM
    Am J Trop Med Hyg; 1999 Mar; 60(3):357-63. PubMed ID: 10466961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil.
    Mertens F; Levitus G; Camargo LM; Ferreira MU; Dutra AP; Del Portillo HA
    Am J Trop Med Hyg; 1993 Sep; 49(3):383-92. PubMed ID: 8372960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele-specific antibodies to Plasmodium vivax merozoite surface protein-1: prevalence and inverse relationship to haemoglobin levels during infection.
    Sepúlveda N; Morais CG; Mourão LC; Freire MF; Fontes CJ; Lacerda MV; Drakeley CJ; Braga ÉM
    Malar J; 2016 Nov; 15(1):559. PubMed ID: 27852258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.
    Pitabut N; Panichakorn J; Mahakunkijcharoen Y; Hirunpetcharat C; Looareesuwan S; Khusmith S
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of HLA-DRB-1 alleles on the production of antibody against CSP, MSP-1, AMA-1, and DBP in Brazilian individuals naturally infected with Plasmodium vivax.
    Storti-Melo LM; da Costa DR; Souza-Neiras WC; Cassiano GC; Couto VS; Póvoa MM; Soares Ida S; de Carvalho LH; Arevalo-Herrera M; Herrera S; Rossit AR; Cordeiro JA; de Mattos LC; Machado RL
    Acta Trop; 2012 Feb; 121(2):152-5. PubMed ID: 22107686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria.
    Soares IS; Levitus G; Souza JM; Del Portillo HA; Rodrigues MM
    Infect Immun; 1997 May; 65(5):1606-14. PubMed ID: 9125537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenetic markers associated with a naturally acquired humoral immune response against an N-terminal antigen of Plasmodium vivax merozoite surface protein 1 (PvMSP-1).
    Cassiano GC; Furini AA; Capobianco MP; Storti-Melo LM; Almeida ME; Barbosa DR; Póvoa MM; Nogueira PA; Machado RL
    Malar J; 2016 Jun; 15():306. PubMed ID: 27255376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of the Pv200L fragment of merozoite surface protein-1 of Plasmodium vivax in clinical isolates from the Pacific coast of Colombia.
    Valderrama-Aguirre A; Zúñiga-Soto E; Mariño-Ramírez L; Moreno LÁ; Escalante AA; Arévalo-Herrera M; Herrera S
    Am J Trop Med Hyg; 2011 Feb; 84(2 Suppl):64-70. PubMed ID: 21292880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
    Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
    Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
    Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
    PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.